TY - JOUR
AU - F. Lei
AU - M. R. Lofwall
AU - P. R. Freeman
AU - E. Slade
AU - R. Vickers-Smith
AU - S. Slavova
A1 - 
AD - Department of Biostatistics, College of Public Health, University of Kentucky, Lexington, Kentucky, USA.;Department of Behavioral Science and Psychiatry, University of Kentucky, Lexington, Kentucky, USA.;Center on Drug and Alcohol Research, University of Kentucky, Lexington, Kentucky, USA.;Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA.;Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, Kentucky, USA.;Kentucky Injury Prevention and Research Center, University of Kentucky, Lexington, Kentucky, USA.
AN - 35610181
BT - J Rural Health
C5 - Education & Workforce;Opioids & Substance Use
CP - 1
DA - Jan
DO - 10.1111/jrh.12669
DP - NLM
ET - 20220524
IS - 1
JF - J Rural Health
LA - eng
PY - 2023
SN - 0890-765X (Print);0890-765x
SP - 186
EP - 196+
ST - Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky
T1 - Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky
T2 - J Rural Health
TI - Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky
U1 - Education & Workforce;Opioids & Substance Use
U3 - 10.1111/jrh.12669
VL - 39
VO - 0890-765X (Print);0890-765x
Y1 - 2023
ER -